Gilead Sciences, Inc.
(NASDAQ : GILD)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 3.40%335.250.0%$4829.12m
BNTXBioNTech SE 4.36%258.480.0%$762.16m
NVAXNovavax, Inc. 3.35%167.3879.4%$739.22m
AMGNAmgen, Inc. -2.11%203.461.4%$563.52m
SNSSSunesis Pharmaceuticals, Inc. -2.32%6.320.7%$441.79m
GILDGilead Sciences, Inc. -2.37%66.031.0%$416.36m
REGNRegeneron Pharmaceuticals, Inc. -2.09%541.682.7%$400.45m
ILMNIllumina, Inc. -0.06%409.693.3%$392.64m
CCXIChemoCentryx, Inc. -6.56%32.212.9%$362.23m
XLRNAcceleron Pharma, Inc. 0.08%173.085.3%$345.73m
VRTXVertex Pharmaceuticals, Inc. -0.40%181.051.9%$258.56m
BIIBBiogen, Inc. -3.61%271.041.7%$234.61m
OCGNOcugen, Inc. -3.01%8.400.0%$173.01m
XENEXenon Pharmaceuticals, Inc. -8.17%30.910.4%$163.63m
CRSPCRISPR Therapeutics AG -0.97%96.060.6%$151.40m

Company Profile

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.